1 The effects of opioid drugs and of Na+ replacement on steroidogenesis in rat adrenal cell suspensions were investigated. 2 In medium containing normal Na+ (156 mM), opioid antagonists but not opioid agonists reduced the steroidogenic response to adrenocorticotrophic hormone1-24 (ACTH1 24) but not to dibutyryl adenosine 3',5' cyclic monophosphate (db cyclic AMP). 3 Replacement of 50% Na+ in the medium by choline had no effect on steroidogenesis, but further reductions in Na+ content reduced the steroidogenic activity of both ACTH1I24 and db cyclic AMP.
Introduction
The plasma corticosteroid response to ether stress is enhanced by the opioid agonist, normorphine, and abolished by the opioid antagonist, naloxone, suggesting that endogenous opioid substances may be involved in the regulation of the hypothalamuspituitary-adrenal (HPA) system (Gibson, Ginsburg, Hall & Hart, 1977) . The observations that adrenocorticotrophic hormone (ACTH) and some of its fragments can interact with opioid receptors (Terenius, 1975) , and that opioid effects can be antagonized by ACTH (Gispen, Buitelaar, Weigant, Terenius & de Wied, 1976) suggested that there might be a similarity between the opioid and ACTH receptors and therefore that the adrenal cortex might be one of the sites at which opioids might act to modify the HPA system. The present study was undertaken to determine whether opioid agonists or antagonists might influence the steroidogenic response to ACTH1 24 in dispersed cell preparations from rat adrenal glands.
Since it is known that the receptor binding of opioid agonists and antagonists is sodium-sensitive (Simon, Hillier, Groth & Edelman, 1975) experiments were also carried out to test the effect of varying the Na+ content of the incubation medium on the adrenal cell response to ACTH1 24 and on the ability of opioids to modify this response. These experiments 0007-1188/79/040671-06 $01.00 led to the observation that the steroidogenic response produced by ACTH1-24 is partially Na+-dependent and that it is inhibited by low concentrations of lithium.
Methods
Isolated adrenal cells were prepared by a slight modification of the method of Lowry, McMartin & Peters (1973) . Eight male rats (200 to 400 g; Wistar) were killed by stunning and exsanguination, the adrenal glands removed, cleared of fat and quartered. The adrenal quarters were then placed in a nylon tube containing 5 ml Hanks medium and 12.5 mg trypsin. The adrenal cells were dispersed by mechanical agitation of the tube contents with a plastic paddle attached to a Fischer-Technik MOT 8 electric motor, the tube being maintained at 37°C in a dry block.
The cells were harvested by centrifugation (100 g; 10 min), and were resuspended in Hanks medium containing albumin (5.3 mg/ml) and lima bean trypsin inhibitor (533 .Lg/ml). ACTH1 24 or dibutyryl adenosine 3',5' cyclic monophosphate (db cyclic AMP) were added in a range of concentrations to duplicate 0.6 ml aliquots of cell suspension, and after incubation at 37°C for 2 h the corticosteroid content of the suspension was estimated spectrophotofluorimetrically (Zenker & Bernstein, 1958 (Figure 1 ). Etorphine and methionine-enkephalin (both 100 ,Ag/ml) did not stimulate corticosteroid production by themselves and were without effect on ACTH1 24-or db cyclic AMP-induced steroidogenesis (Figure 1 ). The opioid antagonists, naloxone and naltrexone, were also inactive by themselves but in high concentrations (100 jAg/ml) they reduced the steroidogenic activity of ACTH1-24 (Figure 2) . However, the opioid antagonists did not reduce steroidogenesis induced by db cyclic AMP (Figure 2 ).
Steroidogenesis in Hanks medium containing reduced Na+ concentrations
The effect of lowering the Na+ content of the Hanks medium from normal (156 mM), on the steroidogenic activity of ACTHI-24 and of db cyclic AMP is shown in Figure 3 . In both cases a 50% reduction in Na+ concentration was without effect, while further reductions produced an inhibition of responses to both ACTH1 24 and to db cyclic AMP. Since steroidogenesis was normal in Hanks solution containing 78 mm Na+ this medium was used to determine the effect of lowered Na+ levels on the actions of opioid drugs (Figure 4) . Etorphine (100 jg/ml) which had been inactive in normal Na+ medium produced a 52% inhibition of ACTH1 24-induced steroidogenesis in medium containing 78 mM Na+, while the inhibitory effect of naloxone was unchanged ( Figure 4) . However, methionine-enkephalin remained inactive against steroidogenesis even in medium containing only 78 mm Na+.
In the above experiments the missing Na+ was replaced by choline. However, in a number of experiments lithium was used as a Na+ substitute and in these, a different pattern of results was obtained ( Figure 5 ). While replacement of 50% of the Na+ by choline had no effect on steroidogenesis, 50% replacement with lithium produced a marked inhibition. A similar degree of inhibition was observed even when only small amounts (1.2 to 7.2 mM) of lithium were added to medium containing normal Na+ concentrations. This inhibitory effect of lithium on steroidogenesis appeared to be selective against ACTH1-24 since the responses of the adrenal cells to db cyclic AMP was unaltered by lithium ( Figure 6 ). 
Discussion
The results obtained in the present study confirm that the adrenal cortex may be a site at which opioid drugs can interfere with the HPA system. However, the doses required were high and it is unlikely that the adrenal cortex is the primary site on which the opioids act to induce modifications of corticosteroid production (Sloan, 1971) , a much more likely candidate being the hypothalamus (George, 1971; Ginsburg, Hall, Hart & Kitchen, 1978) .
The inhibitory effects of the opioids on ACTH1I24-induced steroidogenesis would appear to be an action exerted on the ACTH rather than the opioid receptor, since both agonists and antagonists produced the same effect and since the steroidogenic activity of db cyclic AMP was unaffected. Thus our original hypothesis that there may be some similarity between the opioid and ACTH receptors may be justified, although the possibility that the drugs are acting on some site beyond the ACTH receptor cannot entirely be dismissed.
In physiological Na+ concentrations, opioid antagonists are more effective inhibitors of steroidogenesis than opioid agonists, and it is possible that a direct effect on the adrenal may be of importance in the actions of opioid drugs with a low agonist: antagonist potency ratio (Hughes, Kosterlitz & Leslie, 1975) . The lack of effect of enkephalin may be explained by the rapid breakdown of this compound when exposed to tissues (Meek, Yang & Costa, 1977) . The effect of f,-endorphin on steroidogenesis was not examined in this study, and although the lack of effect of opioids in low concentrations suggests that ,B-endorphin is unlikely to be active on the adrenal cortex, such an effect cannot be ruled out since ,B-endorphin is released along with ACTH in acute stress (Rossier, French, Rivier, Ling, Guillemin & Bloom, 1977) and the characteristics of opioid receptors in different tissues is not uniform (Lord, Waterfield, Hughes & Kosterlitz, 1977) . Matthews & Saffran (1973) reported that replacement of 82% of the NaCl of the medium by choline chloride had no effect on steroidogenesis, although in the present study steroidogenesis induced by ACTHI 24 and by db cyclic AMP was reduced by replacement of 70% of the NaCl by choline chloride.
However, there were differences in the methods used since Matthews & Saffran (1973) superfused adrenals from neonatal rabbits.
Perhaps the most interesting results obtained in this study concern the ability of lithium in low concentrations to inhibit ACTH, 24-induced steroido-genesis. The effect of lithium on steroidogenesis appears to be exerted on the ACTH-adenyl cyclase system since the effects of db cyclic AMP were unaltered. For this reason it does not appear to be due merely to a competition between lithium and Nat since Na+ lack reduced the steroidogenic potency of both ACTH1 24 and of db cyclic AMP. In many other systems the effect of lithium is believed to be due to prevention of increased production of cyclic AMP by hormones and neurotransmitters (Schou, 1976) , and the effect of lithium described here would fall into this general pattern. It is a matter for speculation how far the impairment of ACTH actions by lithium may contribute to the therapeutic effects of the ion in affective disorders. Since these disorders are associated with abnormality in control of the HPA system (Carroll, 1969) , lowering of corticosteroid production by impaired ACTH response of the adrenal cortex may be of significance. Alternatively, the inhibition of ACTH by lithium may not be limited to the adrenal cortex but may extend to brain and to the behavioural effects of the peptide (de Wied, 1969) , some of which have been shown to resemble anxiety states (File & Vellucci, 1978) . 
